A worldwide view of bladder cancer

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder?

Urologic oncology·2011

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.

Urologic oncology·2011

Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study.

Urologic oncology·2011

PSA response to secondary androgen deprivation following failed treatment of metastatic prostate cancer with the antiandrogen casodex.

Urologic oncology·2011

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study.

Urologic oncology·2011

[Comparative study of surgical efficacy in open versus laparoscopic prostatectomy: virtual prostate reconstruction and periprostatic tissue quantification].

Actas urologicas espanolas·2008

Second Time's a Charm? A Matched Case-Control Analysis of Revision Urethroplasty versus Primary Urethroplasty.

The Journal of urology·2026

Delineating the Long-Term Incidence of Urethral Complications After Prostate Cancer Treatment: A Population-Based Analysis.

The Journal of urology·2026

Quality of life improves with improved continence in people with spina bifida.

The Journal of urology·2026

Microplastics in Urinary Calculi: Evidence from Human Urinary Stones.

The Journal of urology·2026

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Oncogene·2026

Research advances in the recurrence patterns of glioblastoma.

Biochimica et biophysica acta. Reviews on cancer·2026

IGF2BP3 promotes esophageal squamous cell carcinoma progression by regulating global protein translation.

Biochimica et biophysica acta. Molecular basis of disease·2026

Progress in Hydroxyapatite Nanocarriers for Targeted and Enhanced Osteoporosis Treatment: A Comprehensive Review.

Molecular biotechnology·2026

ATF4 and FGFR4 cooperatively support thyroid cancer progression and CAF-associated tumor-promoting features.

Endocrine·2026

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Genes & diseases·2026

Related Experiment Videos

A worldwide view of bladder cancer

Related Concept Videos

What is the available evidence to support immediate adjuvant intravesical chemotherapy after transurethral resection of superficial transitional cell carcinoma of the bladder?

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues.

Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study.

PSA response to secondary androgen deprivation following failed treatment of metastatic prostate cancer with the antiandrogen casodex.

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study.

[Comparative study of surgical efficacy in open versus laparoscopic prostatectomy: virtual prostate reconstruction and periprostatic tissue quantification].

Second Time's a Charm? A Matched Case-Control Analysis of Revision Urethroplasty versus Primary Urethroplasty.

Delineating the Long-Term Incidence of Urethral Complications After Prostate Cancer Treatment: A Population-Based Analysis.

Quality of life improves with improved continence in people with spina bifida.

Microplastics in Urinary Calculi: Evidence from Human Urinary Stones.

Imbalanced p53-RB signaling triggers cGAS-STING-mediated immune activation in early oral cancer development.

Research advances in the recurrence patterns of glioblastoma.

IGF2BP3 promotes esophageal squamous cell carcinoma progression by regulating global protein translation.

Progress in Hydroxyapatite Nanocarriers for Targeted and Enhanced Osteoporosis Treatment: A Comprehensive Review.

ATF4 and FGFR4 cooperatively support thyroid cancer progression and CAF-associated tumor-promoting features.

DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL co-culture system.

Related Experiment Videos

A worldwide view of bladder cancer

Related Concept Videos

Related Articles